Erasca priced an upsized offering of 31,428,572 shares at $17.50, targeting roughly $516.0 million in net proceeds.

Key Highlights:

  • Underwriting agreement: 31,428,572 shares priced at $17.50 per share; underwriters buy at $16.45 per share.
  • Overallotment: 30-day option to purchase up to 4,714,285 additional shares at the public offering price.
  • Proceeds: Expected net proceeds of ~ $516.0 million; ~ $593.5 million if option exercised in full.
  • Timing and registration: Offering expected to close July 15, 2026, under Form S-3 shelf registration (No. 333-297427).
  • Use of proceeds: To fund R&D, development programs, working capital and general corporate purposes.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.